Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eupatilin vs Rebamipide for NSAID-induced Gastroenteropathy
NCT04885751Phase 4Unknown
- Sponsor
- SMG-SNU Boramae Medical Center
- Start
- Jun 2021
- Primary completion
- Dec 2021
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of eupatilin in NSAID-induced gastroenteropathy, sponsored by SMG-SNU Boramae Medical Center. Status: unknown.
02
Drugs
eupatilin
03
Conditions
NSAID-induced gastroenteropathy
Beyond the preview
Go deeper on NCT04885751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04885751.